The efficacy and safety of lecanemab 10mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Nav

General Info

Geography

Global

Coverage type

Global

Time period covered

01/2016 - 12/2023

Data type

Scientific literature

Keywords

Alzheimer's disease and other dementias

Citation

Authors

Abdelazim K, Allam AA, Afifi B, Abdulazeem H, Elbehiry AI

Journal

Neurol Sci

Volume

Issue

Pages

3583-3597

Publication year

2024

Suggested citation

Abdelazim K, Allam AA, Afifi B, Abdulazeem H, Elbehiry AI. The efficacy and safety of lecanemab 10mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials. Neurol Sci. 2024; 45(8): 3583-3597.

DOI

101007s1007202407477w

PMID

38565747

GHDx Entry last modified on: Mar 25, 2025

Header sites

Search form

Main menu

The efficacy and safety of lecanemab 10mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Nav